Explore Charles Rivers Biologics Testing Solutions – take a fresh look!
Less than 1% of all drug candidates entering clinical trials reach the market, which means you need a partner with a proven track record.
With over 40,000 tests run annually at global biologics testing facilities and 200+ products supported; Charles River can provide comprehensive testing services for a wide range of modalities. These include monoclonal antibodies/recombinant proteins, viral vectors, vaccines, and cell therapies. Count on us to ensure your biologic is safe, effective, and able to pass regulatory scrutiny.
Attend a two-day event with experts on viral clearance and viral safety, taking place in Philadelphia, PA on September 10-11, 2024. Gain insights from industry leaders and academic researchers who are defining the way we evaluate biologics, vaccines, and advanced therapeutic medicinal products (ATMPs).
Wonder what it would be like to work with a partner that has over 30 years of experience designing and performing viral clearance projects? See for yourself.
Take a deeper look at the challenges often encountered when designing viral clearance studies and learn how to ensure study success. Explore how regulatory guidelines can differ based on product, how to avoid contamination of test materials, and more.
Dive into the evolving landscape of viral clearance practices, focusing on the implementation of continuous manufacturing, advancements in study design, and the implications for cell and gene therapy products.
Interested in reducing materials, time, and labor required for traditional viral spiking? This method may be for you.
Watch this presentation if you need help reducing contamination risks in your advanced therapy.
Get caught up on the ICH Q5A revision impact and understand the importance of starting material in cell and gene therapy products.
Learn about safer, faster, and more robust ways to release cell banks without animal testing.
